We are live on ! Find out more
AV

ASR Vermogensbeheer Portfolio holdings

AUM $8.5B
1-Year Est. Return 25.14%
This Fund
S&P 500
This Quarter Est. Return
-3.12%
1 Year Est. Return
+25.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.5B
AUM Growth
-$96.1M
Cap. Flow
+$411M
Cap. Flow %
4.83%
Top 10 Hldgs %
34.38%
Holding
534
New
8
Increased
456
Reduced
39
Closed
2

Top Buys

1
AZN icon
AstraZeneca
AZN
+$162M
2
SUNB
Sunbelt Rentals Holdings
SUNB
+$41.2M
3
NVDA icon
NVIDIA
NVDA
+$33.2M
4
UBS icon
UBS Group
UBS
+$19.4M
5
AAPL icon
Apple
AAPL
+$16.9M

Top Sells

1
META icon
Meta Platforms (Facebook)
META
+$17.1M
2
BDX icon
Becton Dickinson
BDX
+$8.94M
3
SLB icon
SLB Ltd
SLB
+$7.67M
4
GIB icon
CGI
GIB
+$4.75M
5
AMAT icon
Applied Materials
AMAT
+$3.24M

Sector Composition

1 Technology 30.92%
2 Financials 13.2%
3 Healthcare 11.8%
4 Consumer Discretionary 10.12%
5 Communication Services 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.95T
$584M 6.87%
3,350,520
+181,143
+6% +$33.2M
AAPL icon
2
Apple
AAPL
$4.88T
$543M 6.39%
2,139,525
+64,757
+3% +$16.9M
MSFT icon
3
Microsoft
MSFT
$2.93T
$381M 4.48%
1,029,535
+27,844
+3% +$11.7M
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.2T
$309M 3.63%
1,074,632
+30,109
+3% +$9.46M
AMZN icon
5
Amazon
AMZN
$2.66T
$303M 3.56%
1,455,453
+42,631
+3% +$9.39M
AVGO icon
6
Broadcom
AVGO
$1.78T
$221M 2.6%
715,172
+14,845
+2% +$4.88M
AZN icon
7
AstraZeneca
AZN
$261B
$163M 1.92%
+841,921
New +$162M
JPM icon
8
JPMorgan Chase
JPM
$912B
$146M 1.72%
497,274
+4,047
+0.8% +$1.23M
GOOG icon
9
Alphabet (Google) Class C
GOOG
$4.19T
$145M 1.7%
505,059
+9,523
+2% +$2.99M
LLY icon
10
Eli Lilly
LLY
$1.05T
$128M 1.5%
138,714
-666
-0.5% -$675K
META icon
11
Meta Platforms (Facebook)
META
$1.65T
$127M 1.49%
221,511
-26,723
-11% -$17.1M
TSLA icon
12
Tesla
TSLA
$1.43T
$106M 1.25%
285,530
+4,337
+2% +$1.79M
COST icon
13
Costco
COST
$415B
$104M 1.22%
104,408
+1,796
+2% +$1.75M
V icon
14
Visa
V
$681B
$101M 1.19%
335,397
+9,334
+3% +$3M
NFLX icon
15
Netflix
NFLX
$291B
$88M 1.03%
914,913
+177,642
+24% +$15.7M
SLB icon
16
SLB Ltd
SLB
$70B
$81.3M 0.96%
1,581,260
-158,084
-9% -$7.67M
AMAT icon
17
Applied Materials
AMAT
$426B
$81.1M 0.95%
237,204
-9,622
-4% -$3.24M
AWK icon
18
American Water Works
AWK
$26.3B
$71.6M 0.84%
526,068
+16,466
+3% +$2.18M
JNJ icon
19
Johnson & Johnson
JNJ
$609B
$70.6M 0.83%
288,657
+5,502
+2% +$1.28M
PEP icon
20
PepsiCo
PEP
$186B
$68.1M 0.8%
438,353
+4,388
+1% +$684K
DHR icon
21
Danaher
DHR
$144B
$64M 0.75%
337,663
+1,733
+0.5% +$369K
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.06T
$63.5M 0.75%
132,513
+3,934
+3% +$1.93M
TJX icon
23
TJX Companies
TJX
$170B
$61.3M 0.72%
384,103
+2,426
+0.6% +$378K
UNH icon
24
UnitedHealth
UNH
$395B
$57.3M 0.67%
211,700
+9,103
+4% +$2.71M
SPGI icon
25
S&P Global
SPGI
$133B
$52.3M 0.62%
122,993
+6,181
+5% +$2.87M
1
2 3 4 5

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return

ASR Vermogensbeheer's Q1 2026 Portfolio in Review

As of Q1 2026, ASR Vermogensbeheer held 534 positions worth $8.5B, down 1.1% from $8.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

ASR Vermogensbeheer deployed $411M of net new capital in Q1 2026, opening 8 new positions and adding to 456 existing holdings. Its largest new stake was AstraZeneca: 841,921 shares worth $163M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $17.1M trimmed.

  • ASR Vermogensbeheer's largest Q1 2026 buy was AstraZeneca: 841,921 shares worth $163M.
  • ASR Vermogensbeheer added most to NVIDIA in Q1 2026, an estimated $33.2M increase.
  • ASR Vermogensbeheer's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $17.1M.
  • ASR Vermogensbeheer fully exited Amrize Ltd in Q1 2026, selling an estimated $1.58M.
  • ASR Vermogensbeheer's ten largest holdings make up 34% of its $8.5B portfolio in Q1 2026.
  • ASR Vermogensbeheer opened 8 new positions and closed 2 in Q1 2026.
  • ASR Vermogensbeheer's portfolio value fell 1.1% quarter-over-quarter to $8.5B.

Based on ASR Vermogensbeheer's 13F filing for Q1 2026, filed 30 Apr 2026.